Home
Addiction
Report Highlights Serious Side Effects of Breast Cancer Drugs
According to a report from the Agency for Healthcare Research and Quality, three drugs that are used to reduce a woman's chance of getting breast cancer have also been shown to cause serious side effects and also carry risks of other adverse effects.
Breast cancer is the second most commonly diagnosed cancer among women (after skin cancer), with more than 190,000 new cases diagnosed each year in the United States and breast cancer is estimated to cause more than 40,000 deaths per year. The National Cancer Institute estimates that nearly 15 percent of women born today will develop breast cancer in their lifetimes. Most cases of breast cancer occur in women with no specific risk factors other than age and gender, although family history of ovarian and breast cancer is associated with higher risk.
The report is based on a review of studies of the use of medications to reduce the risks of getting breast cancer in women.
Tamoxifen, raloxifene and tibolone can be prescribed to women with a family history of breast cancer or other risk factors, but prescribing practices vary widely. According to the study, all three drugs significantly reduce invasive breast cancer in midlife and older women, but benefits and adverse effects can vary depending on the drug and the patient.
The study found that all three drugs do reduce the occurrence of breast cancer but have various side effects. The most common side effects for tamoxifen are flushing and other vasomotor symptoms (e.g., night sweats, hot flashes), vaginal discharge and other vaginal symptoms such as itching or dryness; for raloxifene, side effects include vasomotor symptoms and leg cramps; and for tibolone, side effects include vaginal bleeding.
The study also found that each drug carried risks of adverse effects. Tamoxifen increases risks of endometrial cancer, hysterectomies and cataracts. Tamoxifen and raloxifene increase risk of blood clots, although tamoxifen's risk is greater. Tibolone carries an increased risk of stroke.
References:
1. Heidi D. Nelson, et al. Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer. Annals of Internal Medicine. 17 November 2009, Volume 151 Issue 10.
Related Articles
New research has found that hormone therapy used to treat men with advanced prostate cancer is associated with an increased chance of developing various heart problems.
The findings of the
|
Several studies had previously suggested that regular physical exercise reduces the breast cancer risk of women.
However, it has been unknown just how much exercise women should take in,
|
Researchers have provided a possible mechanism to link high dietary consumption of genistein-containing foods with lower rates of prostate cancer metastasis and mortality. They identified
|
A study conducted at Fred Hutchinson Cancer Research Center suggests women who have a history of migraines have a significantly lower risk of breast cancer.
"We found that, overall,
|
|
Most studies indicate that there is a weak association between moderate alcohol consumption and the incidence of breast cancer, and that the risk of breast cancer increases as the level of
|
Latest Health News
 Tuesday, 09 February 2010
A Mediterranean diet may help people avoid the small areas of brain damage that can lead to problems with thinking
|
 Tuesday, 09 February 2010 {loadposition cardio_ads}
High blood pressure appears to predict the progression to dementia in older adults with impaired
|
 Monday, 08 February 2010
Workers exposed to tricholorethylene (TCE), a chemical once widely used to clean metal such as auto parts, may be at
|
 Monday, 08 February 2010
Consuming two or more soft drinks per week increased the risk of developing pancreatic cancer by nearly twofold
|
 Monday, 08 February 2010
The benefits of marijuana in tempering or reversing the effects of Alzheimer's disease have been challenged in a new
|
 |
 |
 |
 |
 |
 |
 |